EVIDENCE. COMPARISONS. CLEAR NEXT STEPS.FOR US CLINIC TEAMS PROCUREMENT RESEARCH
Scorecard

How should the clinic run the assessment and transition?

Dose Diligence research deskSection 09 · Page 13 of 15Last updated 17 Nov 2026

Use one evidence register and staged approvals. A proposed five-step process follows; elapsed time depends on evidence availability and the complexity of specialist review.

  1. Freeze the requirement. Approve scenarios, mandatory states, budgets, weights, minimums and stretch targets before reviewing commercial offers.
  2. Qualify the arrangement. Complete the gates, record source dates and assign unresolved questions. Do not start a live pilot while a material gate is on HOLD.
  3. Score independently. Have operations, finance and technology reviewers score their areas before a joint moderation meeting. Preserve disagreements and the evidence that resolved them.
  4. Pilot within approved scope. Use a clinically approved cohort, defined duration and stop conditions. Include difficult workflows; do not test only straightforward self-pay starts.
  5. Release volume in stages. Reconcile open orders and charges, confirm patient communications and prescription responsibilities, and maintain an approved rollback route.

Suggested internal governance is weekly review during launch, monthly operating review after stabilisation and quarterly commercial reassessment. Reopen relevant gates immediately after a material product, facility, ownership, licence, quality, regulatory or data-flow change.

Use these workbook columns:

Assessment ID | criterion/gate | requirement | supplier claim | source or document ID | source date | reviewer | evidence status | raw score | evidence ceiling | final score | weighted points | unresolved issue | owner | due date

For public research or free-tool intake, request redacted business documents and aggregate operating data—not patient identifiers or prescription images. Any patient-level implementation testing should occur within the clinic’s approved privacy and security arrangements.

What should the board-ready decision page contain?

  • Exact arrangement, scope and review date.
  • Seven gate decisions with named approvals.
  • Weighted score, evidence coverage and important rating sensitivities.
  • Clinic cost and patient affordability reported separately.
  • Mandatory state coverage and documented exclusions.
  • Maximum contractual exposure and funding requirement.
  • Primary dependencies and validated fallback coverage.
  • Unresolved non-gate conditions, owners and deadlines.
  • Pilot acceptance, stop conditions and transition responsibilities.
  • Next review date and events that trigger requalification.

The decision should read: approve this defined arrangement for this cohort and volume, subject to these conditions—not approve this supplier for everything.

Sources cited on this page

    See the section’s source register for the research context.

    Section sources →